Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

9.11
Delayed Data
As of Jul 31
 -0.10 / -1.09%
Today’s Change
4.74
Today|||52-Week Range
11.71
+4.00%
Year-to-Date

Today’s Trading

Previous close9.21
Today’s open9.18
Day’s range-- - --
Volume319,275
Average volume (3 months)515,878
Market cap$451.9M
Dividend yield--
Data as of 07/31/2015

Growth & Valuation

Earnings growth (last year)+140.00%
Earnings growth (this year)+20.83%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)+6.09%
P/E ratio15.9
Price/Sales3.42
Price/Book2.93

Competitors

 Today’s
change
Today’s
% change
XNPTXenoport Inc+0.16+2.24%
LIFEaTyr Pharma Inc+0.61+3.36%
ZGNXZogenix Inc0.000.00%
PRTKParatek Pharmaceutic...+0.26+1.04%
Data as of 07/31/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)$0.13
Annual revenue (last year)$134.8M
Annual profit (last year)$25.2M
Net profit margin18.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Friedhelm Blobel
Chief Financial Officer &
Senior Vice President
Wai-Shun Wilson Cheung
Corporate headquarters
Foster City, California

Forecasts